AI Agents Start Shopping, AI Designs Vaccines and Zero Trust Gets Serious
AI is moving from demos into commerce, healthcare and enterprise control planes at the same time.
On this episode of Techstrong Gang, hosts Alan Shimel and Mike Vizard, joined by Jon Swartz and Ira, examine Visa’s partnership with OpenAI to support secure payments for AI agents, a new AI-designed universal vaccine tested in humans and Zscaler’s push for zero-trust security around agentic AI.
The first segment, Agentic AI Shopping Spree, looks at how payments infrastructure is being rebuilt for AI agents. Visa’s partnership with OpenAI signals that agentic commerce is becoming real, with approvals, spending limits and transaction controls moving into the design of AI shopping systems.
The second segment, AI Medical Breakthrough, focuses on the healthcare implications of AI-designed science. Early human-trial results around a future-proof vaccine approach suggest AI could play a much larger role in anticipating and responding to evolving threats.
The final segment, Zscaler Field Trip, examines how zero-trust models are adapting to the rise of agentic AI. If agents are going to transact, access systems and make decisions, enterprises will need stronger controls around identity, access and runtime behavior.
Taken together, these stories point to the same broader shift: AI is no longer just generating content. It is starting to transact, design and act.
